LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

LMAT

$80.98

Updated: 23/09/2026, 00:57:16

Market Cap
$1.85B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Stock valuation chart
One-year closing share-price history for LMAT
Company Profile

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

USD
NASDAQ
CEO: George W. LeMaitre
Employees: 651
https://www.lemaitre.com
Asset Summaries
Latest generated summaries for LMAT

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for LMAT.
Share price
$80.98
Market cap
$1.85B
Exchange
NASDAQ
Currency
USD
CEO
George W. LeMaitre
Employees
651
IPO date
19/10/2006
Beta
0.493
Last dividend
$0.00
Day range
$79.83 – $81.32
52-week range
$78.22 – $118.01
1-day performance
2.25%
1-year performance
3.53%
Current drawdown (1Y)
-31.38%
CIK
0001158895
CUSIP
525558201
ISIN
US5255582018
Created
07/12/2025, 05:04:56
Last update
23/09/2026, 00:57:16

Track LeMaitre Vascular, Inc. with an AI analyst

See which prediction-market events move LMAT, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.